Stockreport

IBRX Stock Jumps on Progress in NK Cell Therapy Production [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF Shares of ImmunityBio IBRX rose more than 7% on Friday after the company announced that it completed two manufacturing engineering programs for its autologous memory cy [Read more]